Theranostics 2023; 13(7):2072-2087. doi:10.7150/thno.81198 This issue Cite

Research Paper

Transcription factor TOX maintains the expression of Mst1 in controlling the early mouse NK cell development

Liang Luo1,2*, Peiran Feng1*, Quanli Yang3*, Wenkai Lv2, Wanqing Meng2, Zhinan Yin2,3, Zhizhong Li1,4, Guodong Sun1,4✉, Zhongjun Dong5,6✉, Meixiang Yang1,2,3✉

1. The Fifth Affiliated Hospital (Heyuan Shenhe People's Hospital), Jinan University, Heyuan 517000, China
2. The Biomedical Translational Research Institute, Guangzhou Key Laboratory for Germ-free animals and Microbiota Application, Key Laboratory of Ministry of Education for Viral Pathogenesis & Infection Prevention and Control, School of Medicine, Jinan University, Guangzhou, 510632, China
3. Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine, Zhuhai People's Hospital Affiliated with Jinan University, Jinan University, Zhuhai, 519000, China
4. Department of Orthopedics, The First Affiliated Hospital, Jinan University, Guangzhou, 510630, China
5. The First Affiliated Hospital of Anhui Medical University and Institute for Clinical Immunology, Anhui Medical University, Anhui, 230032, China
6. School of Medicine and Institute for Immunology, Tsinghua University, Beijing, 100084, China
*These authors contributed equally to this work

Citation:
Luo L, Feng P, Yang Q, Lv W, Meng W, Yin Z, Li Z, Sun G, Dong Z, Yang M. Transcription factor TOX maintains the expression of Mst1 in controlling the early mouse NK cell development. Theranostics 2023; 13(7):2072-2087. doi:10.7150/thno.81198. https://www.thno.org/v13p2072.htm
Other styles

File import instruction

Abstract

Graphic abstract

Rationale: TOX is a DNA-binding factor required for the development of multiple immune cells and the formation of lymph nodes. However, the temporal regulation mode of TOX on NK cell development and function needs to be further explored.

Methods: To investigate the role of TOX in NK cells at distinct developmental phases, we deleted TOX at the hematopoietic stem cell stage (Vav-Cre), NK cell precursor (CD122-Cre) stage and late NK cell developmental stage (Ncr1-Cre), respectively. Flow cytometry was used to detect the development and functional changes of NK cell when deletion of TOX. RNA-seq was used to assess the differences in transcriptional expression profile of WT and TOX-deficient NK cells. Published Chip-seq data was exploited to search for the proteins directly interact with TOX in NK cells.

Results: The deficiency of TOX at the hematopoietic stem cell stage severely retarded NK cell development. To a less extent, TOX also played an essential role in the physiological process of NKp cells differentiation into mature NK cells. Furthermore, the deletion of TOX at NKp stage severely impaired the immune surveillance function of NK cells, accompanied by down-regulation of IFN-γ and CD107a expression. However, TOX is dispensable for mature NK cell development and function. Mechanistically, by combining RNA-seq data with published TOX ChIP-seq data, we found that the inactivation of TOX at NKp stage directly repressed the expression of Mst1, an important intermediate kinase in Hippo signaling pathway. Mst1 deficient at NKp stage gained the similar phenotype with Toxfl/flCD122Cre mice.

Conclusion: In our study, we conclude that TOX coordinates the early mouse NK cell development at NKp stage by maintaining the expression of Mst1. Moreover, we clarify the different dependence of the transcription factor TOX in NK cells biology.

Keywords: TOX, NK cell, Mst1, cell development, immune surveillance


Citation styles

APA
Luo, L., Feng, P., Yang, Q., Lv, W., Meng, W., Yin, Z., Li, Z., Sun, G., Dong, Z., Yang, M. (2023). Transcription factor TOX maintains the expression of Mst1 in controlling the early mouse NK cell development. Theranostics, 13(7), 2072-2087. https://doi.org/10.7150/thno.81198.

ACS
Luo, L.; Feng, P.; Yang, Q.; Lv, W.; Meng, W.; Yin, Z.; Li, Z.; Sun, G.; Dong, Z.; Yang, M. Transcription factor TOX maintains the expression of Mst1 in controlling the early mouse NK cell development. Theranostics 2023, 13 (7), 2072-2087. DOI: 10.7150/thno.81198.

NLM
Luo L, Feng P, Yang Q, Lv W, Meng W, Yin Z, Li Z, Sun G, Dong Z, Yang M. Transcription factor TOX maintains the expression of Mst1 in controlling the early mouse NK cell development. Theranostics 2023; 13(7):2072-2087. doi:10.7150/thno.81198. https://www.thno.org/v13p2072.htm

CSE
Luo L, Feng P, Yang Q, Lv W, Meng W, Yin Z, Li Z, Sun G, Dong Z, Yang M. 2023. Transcription factor TOX maintains the expression of Mst1 in controlling the early mouse NK cell development. Theranostics. 13(7):2072-2087.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image